Crowdonomics
Siren Biotechnology, Inc.

Reg CF · Preferred Stock · Apr 2025

ClosedReg CFPreferred Equity
via WeFunder · last checked Aug 17, 2026
Raised
$0 / $5M max
0% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$0
−$3.7M
FY2023
$0
−$4.7M
FY2024
RevenueNet income
Metric
FY2023 unaudited
FY2024 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$3,659,223
-$4,666,672
Taxes paid
$0
$0
Balance sheet
Cash
$2,581,976
$17,448,263
Accounts receivable
$0
$0
Total assets
$2,741,295
$17,539,808
Short-term debt
$117,038
$784,882
Long-term debt
$0
$0
Total liabilities
$117,038
$784,882
Other
Headcount
—
6

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Price / share$6.41
Shares offered7,800

Offering details

Target$49,996
Max$4,999,995
Min investment—
OpenedApr 2, 2025
DeadlineApr 30, 2026
ClosedApr 30, 2026
Days active393

Links & provenance

Source: SEC EDGAR
0001670254-25-000274
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.